Abstract: Disclosed is a retainer to couple a first component to a second component having a rib via a male fastener. The retainer includes a body portion, one or more tabs coupled to the body portion; and retention clips resiliently coupled to the body portion. The body portion includes or defines a female fastener to receive the male fastener. The one or more tabs and at least one of the plurality of retention clips cooperate to define a cavity to receive the rib. The plurality of retention clips is arranged to engage and retain the rib within the cavity. In some examples, the retainer is a stamped retainer clip.

Abstract: Methods of treating autism, autistic spectrum disorders or Fragile X syndrome comprised of administering molecules that engage the cystine-glutamate exchange (System xc?) and/or elevate the extracellular levels of glutathione in the CNS. Preferred compounds are cysteine/cystine prodrugs or N-acetyl cysteine (NAC) prodrugs.

Abstract: Methods of treating Parkinson's Disease comprising administering compounds that up-regulate cystine-glutamate exchange (system Xc?) and/or increase glutathione levels in the brain cells. Preferred compounds are cysteine/cystine prodrugs or N-acetyl cysteine (NAC) prodrugs.

Abstract: Methods for the treatment of neuropsychiatric disorders such as anxiety are disclosed. The methods involve modulating the expression of the angiotensin IV receptor or modulating the biological activity of the angiotensin IV receptor by utilizing antagonists to the receptor. Also disclosed are methods for identifying antagonists of the angiotensin IV receptor that are effective to reduce anxiety in a subject.

Abstract: The present invention relates to selective adrenergica2B antagonists alone, selective adrenergic?2B antagonists in combination with norepinephrine reuptake inhibitors (NRI) (as a single compound or as a combination of two or more compounds), or selective adrenergic?2B antagonists in combination with dual norepinephrine reuptake inhibitors/serotonin reuptake inhibitors (NRI/SRI) (as a single compound or as a combination of two or more compounds) and methods of their use in the treatment of vasomotor symptoms.